DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Mertansine
Mertansine
Predictive QSAR Tools to Aid in Early Process Development of Monoclonal Antibodies
Advances and Limitations of Antibody Drug Conjugates for Cancer
Pharmacokinetics and Biodistribution of the Anti-Tumor Immunoconjugate, Cantuzumab Mertansine (Huc242-DM1), and Its Two Components in Mice
Maytenus Ovatus (Schweinf.) an African Medicinal Plant Yielding Potential Anti-Cancer Drugs
WO 2015/028850 Al 5 March 2015 (05.03.2015) P O P C T
WO 2013/152252 Al 10 October 2013 (10.10.2013) P O P C T
(INN) for Biological and Biotechnological Substances
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances" WHO/EMP/RHT/TSN/2013.1
Antibody–Drug Conjugates for Cancer Therapy
IMSN Letter on Antibody-Drug Conjugates 2015 03 23
(12) United States Patent (10) Patent No.: US 9,579,365 B2 Klink Et Al
(INN) for Biological and Biotechnological Substances
T-DM1): Mechanism of Action of Its Cytotoxic Component Retained with Improved Tolerability
Product Data Sheet
WHO Drug Information Vol
Implementing Antibody-Drug Conjugates (Adcs) in HER2-Positive Breast Cancer: State of the Art and Future Directions Emanuela Ferraro1 , Joshua Z
Safety of Medicines
Antibody–Drug Conjugates for Cancer Therapy
Top View
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances" WHO/EMP/RHT/TSN/2013.1
Analysis of the Efficacy and Cytotoxicity of a Synthesized Anti-HER2 Antibody-Drug Conjugate
IMSN Open Letter on Antibody-Drug Conjugate 2151012
Antibody–Drug Conjugates for the Treatment of Breast Cancer
Qualifying Therapeutic Discovery Project Grants
Combinations of an Anti-HER2 Antibody-Drug Conjugate And
"The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances" WHO/EMP/RHT/TSN/2013.1
QSAR Model Development for Early Stage Screening of Monoclonal Antibody Therapeutics to Facilitate Rapid Developability
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Tubulin Inhibitor-Based Antibody-Drug Conjugates for Cancer Therapy
Pharmacokinetics and Biodistribution of the Anti-Tumor Immunoconjugate, Cantuzumab Mertansine (Huc242-DM1), and Its Two Components in Mice